Nathan Connell: Celebrating 100 Years of von Willebrand Disease at ISTH 2026
Nathan Connell, Clinical Chief of Hematology at Brigham and Women’s Faulkner Hospital, shared a post on LinkedIn:
“Excited to be in Paris representing the Boston.
Bleeding Disorders Center for the opening day of ISTH 2026.
I am looking forward to connecting with colleagues from around the world to discuss the latest science and advances in care for people with inherited bleeding disorders, and to supporting my Mass General Brigham colleagues as they present their work.
I am particularly looking forward to the VWF Scientific and Standardization Committee session as we mark 100 years since Erik von Willebrand’s landmark publication describing the bleeding disorder that would ultimately bear his name.
I am also grateful to the International Society on Thrombosis and Haemostasis (ISTH) Scientific Programme Committee for including important sessions focused on improving the diagnosis and management of bleeding disorders in women and girls.
These discussions are essential to addressing persistent gaps in recognition, evidence, and care.
Looking forward to an engaging and productive meeting.”

Other posts featuring Nathan Connell on Hemostasis Today.
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:18Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
-
Aug 26, 2026, 14:17Khurram Nasir: Are We Debating the Wrong Thing About Research in Medical Training?
-
Aug 26, 2026, 14:15Nathan Connell: Why Format Free Publishing Still Demands Formatting?
-
Aug 26, 2026, 14:14Reza Shojaei: China’s Reliance on Imported Albumin Raises Global Plasma Security Concerns
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM
-
Aug 26, 2026, 13:59David McIntosh: Immunoglobulin Stewardship in the Face of Rising Demand